# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-021748
Filing Date
2024-04-24
Accepted
2024-04-24 16:32:43
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20024003x2_defa14a.htm | DEFA14A | 11323
2 |  | ny20024003x2_img1.jpg | GRAPHIC | 2315985
3 |  | ny20024003x2_img2.jpg | GRAPHIC | 2773442
| Complete submission text file | 0001140361-24-021748.txt |  | 7005690

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 24871072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)